GÖTEBORG, Sweden--(BUSINESS WIRE)--Regulatory News:
Meda (STO:MEDAA) has signed a 5-year collaboration agreement with Omega Pharma for SB12 in France, Italy, Belgium and Greece. Omega Pharma is a Belgian company with a leading market position in the OTC segment in these countries.
Meda (STO:MEDAA) has signed a 5-year collaboration agreement with Omega Pharma for SB12 in France, Italy, Belgium and Greece. Omega Pharma is a Belgian company with a leading market position in the OTC segment in these countries.
